Financhill
Buy
61

TARS Quote, Financials, Valuation and Earnings

Last price:
$72.88
Seasonality move :
18.73%
Day range:
$70.84 - $73.90
52-week range:
$38.51 - $76.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.11x
P/B ratio:
9.24x
Volume:
253.7K
Avg. volume:
539.5K
1-year change:
56.31%
Market cap:
$3.1B
Revenue:
$183M
EPS (TTM):
-$2.01

Earnings Data

Next earnings date for TARS
Feb 25
2026
Most recent earnings per share
-$0.30
Beat by $0.03
(Nov 4/2025)
Consensus Estimate
-$0.33
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TARS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $143.6M -- -- $0.05 --
11/04/2025 Q3 $115.2M $118.7M -$0.30 -$0.33 $0.03
08/06/2025 Q2 $95.8M $102.7M -$0.48 -$0.36 -$0.12
05/01/2025 Q1 $72.5M $78.3M -$0.64 -$0.63 -$0.01
02/25/2025 Q4 $58.8M $66.4M -$0.60 -$0.78 $0.18
11/13/2024 Q3 $43.2M $48.1M -$0.61 -$1.00 $0.39
08/08/2024 Q2 $32M $40.8M -$0.88 -$0.80 -$0.08
05/08/2024 Q1 $17.9M $27.6M -$1.01 -$1.25 $0.24
02/27/2024 Q4 $5.9M $13.1M -$1.31 -$1.49 $0.18
11/09/2023 Q3 $361K $1.9M -$1.28 -$1.27 -$0.01
08/10/2023 Q2 -- -- -$1.17 -- --
05/09/2023 Q1 -- $2.5M -$0.88 -- --
03/13/2023 Q4 -- $10M -$0.51 -- --
11/09/2022 Q3 -- -- -$0.84 -- --
08/11/2022 Q2 -- $15.3M -$0.24 -- --
05/10/2022 Q1 -- $539K -$0.98 -- --
03/14/2022 Q4 -- $338K -$0.72 -- --
11/09/2021 Q3 -- $1.2M -$0.76 -- --
08/04/2021 Q2 -- $22M $0.29 -- --
05/11/2021 Q1 -- $33.4M $0.47 -- --
03/31/2021 Q4 -- -- -$0.56 -- --
11/25/2020 Q3 -- -- -$0.50 -- --
06/30/2020 Q2 -- -- -$0.30 -- --
03/31/2020 Q1 -- -- -$0.10 -- --
12/31/2019 Q4 -- -- -$0.13 -- --
09/30/2019 Q3 -- -- -$0.03 -- --

Tarsus Pharmaceuticals, Inc. Earnings Questions

  • How Much did Tarsus Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Tarsus Pharmaceuticals, Inc. reported $118.7M worth of top line sales in its most recent quarter.

  • Did Tarsus Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Tarsus Pharmaceuticals, Inc. announced earnings per share of -$0.30 which represents a beat of analyst forecast a -$0.33 per share.

  • Is Tarsus Pharmaceuticals, Inc. Profitable?

    Tarsus Pharmaceuticals, Inc. reported $110.4M that represents $2.59 per share over the last quarter.

  • What is the Analyst Consensus for Tarsus Pharmaceuticals, Inc. EPS Next Year?

    Tarsus Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$3.07 per share to -$1.43 per share next year representing a decrease of -53.46%.

  • When is Tarsus Pharmaceuticals, Inc.'s Earnings Date?

    Tarsus Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oracle Go Bust?
Will Oracle Go Bust?

After surging earlier this year, shares of cloud computing giant…

Why Is Nebius Stock Up?
Why Is Nebius Stock Up?

Nebius (NASDAQ:NBIS) is an AI infrastructure business that operates large…

Will Robinhood Win Tokenization?
Will Robinhood Win Tokenization?

For many years, cryptocurrency enthusiasts have predicted a mass tokenization…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
62
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 37x

Alerts

Buy
88
CDTX alert for Nov 15

Cidara Therapeutics, Inc. [CDTX] is up 105.38% over the past day.

Buy
60
SRRK alert for Nov 15

Scholar Rock Holding Corp. [SRRK] is up 24.38% over the past day.

Buy
86
ZCSH alert for Nov 15

Grayscale Zcash Trust (ZEC) [ZCSH] is up 21.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock